Navigation Links
Gene By Gene Rejects BRCA1/2 Patent Infringement Claims by Myriad and Joins Ambry Genetics to Sue Myriad for Violating Federal Antitrust Laws
Date:8/15/2013

HOUSTON, Aug. 15, 2013 /PRNewswire/ -- Gene By Gene, Ltd. announced that it is teaming with Ambry Genetics to defend against Myriad Genetics' patent infringement lawsuits against both companies in connection with the BRCA1/2 tests being offered by Gene By Gene and Ambry Genetics.  Both companies are also countersuing Myriad for violations of the Federal Antitrust Act.

On June 13, 2013, immediately following the United States Supreme Court's 9-0 landmark decision against Myriad in "Association For Molecular Pathology v. Myriad Genetics," Gene By Gene announced its intention to offer fast, accurate and affordable BRCA1/2 testing to the public.

"The Supreme Court was very clear that gene sequences, even when isolated, cannot be patented," said Gene By Gene President Bennett Greenspan. "In light of this ruling we are pleased that we can now offer Americans the benefit of this more affordable test that we have already successfully offered to overseas clients."

Gene By Gene has been providing BRCA1/2 tests to individuals outside the U.S. since 2012. Those tests are processed at the company's Genomic Research Center in Houston, a CLIA-registered lab.  The company has processed various genetic tests – including BRCA1/2 -- for close to a million individuals and organizations globally.

Yesterday Gene By Gene also filed a declaration with the court outlining the details of its BRCA1/2 test, which it will continue to offer to the public.

Greenspan added, "We look forward to a swift resolution of this litigation to level the playing field for test providers, and to enable greater numbers of people to benefit from the genomics revolution."

About Gene By Gene Ltd.

Founded in 2000, Gene By Gene, Ltd. provides reliable DNA testing, focused on ancestry, health, research and paternity, to a wide range
'/>"/>

SOURCE Gene By Gene, Ltd.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Court Partially Rejects DOJ "Stay" in Decade-Long Battle for Emergency Contraception Over the Counter
2. Essential Medical Dismisses Patent Case against Masimo and Cercacor
3. Ampio Awarded US and Canadian Patents that will Bolster the Commercialization of Optina™ for the treatment of Diabetic Macular Edema (DME)
4. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
5. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
6. Biodels Intellectual Property Position Strengthened for Ultra-Rapid-Acting Insulin Programs by Notice of Intent to Grant from European Patent Office
7. DURECT Announces Issuance of U.S. Patents Covering ORADUR® Technology
8. Broad Patent Protection Granted for iBio Immunomodulator
9. Bio-AMD, Inc.; Patent Application for Cartridge Test Cap
10. Coloplast Wins Patent Infringement Verdict Against Generic Medical Devices, Inc.
11. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... August 31, 2015 A ... global cardiovascular monitoring and diagnostic devices market stood ... to reach a value of approximately US$7.0 billion ... between 2013 and 2019. The title of the ... (ECG, Holter Monitors, Event Monitors, Cardiovascular Diagnostic Catheters, ...
(Date:8/31/2015)... 31, 2015  Regulatory affairs professionals work at ... are often strict and legislation is ever-changing. The ... for professionals who have a deep understanding of ... product lifecycle and demonstrate its use across various ... California, Irvine Extension , in partnership with the ...
(Date:8/31/2015)... and MOUNTAIN VIEW, Calif. , Aug. ... ; EURONEXT: SAN) and the life sciences team at ... care and outcomes for people with type 1 and ... treatments and devices with Google,s expertise in analytics, miniaturized ... explore how to improve diabetes care by developing new ...
Breaking Medicine Technology:Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 2Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 3Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 4Cardiovascular Monitoring and Diagnostic Devices Market to Reach US$7.0 Billion in 2019 Owing to Global Rise in Diabetes and Obesity: Transparency Market Research 5UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 2Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 3Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 4Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 5Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes 6
... UCB) and U.S. based partner Immunomedics Inc. (Nasdaq: ... IIb study, EMBLEM™, showed that certain doses of epratuzumab ... in disease activity in adult patients with moderate to ... designed to evaluate the efficacy and safety of epratuzumab ...
... innovator of Packaging Execution Systems (PES) for the pharmaceutical ... engineering, automation and manufacturing optimization services company, today announced ... Service Provider (SSP). VCG will now sell, install and ... United States. The SSP program is ...
Cached Medicine Technology:Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 2Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 3Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 4Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 5Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 6Epratuzumab Phase IIb Data Presented at ACR Show Pipeline Drug had Positive Effect in Patients Suffering From Moderate to Severe Systemic Lupus Erythematosus 7Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements 2Systech International and Vantage Consulting Group Partner to Address Emerging U.S. Pharmaceutical Regulatory Requirements 3
(Date:8/31/2015)... ... ... MeYou Health ®, a social well-being company and wholly owned subsidiary ... including an in-app step tracker. , Walkadoo is a pedometer-based walking program ... broadly assign every Walkadoo member 10,000 steps a day (as is typical for many ...
(Date:8/31/2015)... ... August 31, 2015 , ... There’s big news for ZendyHealth ... healthcare industry. , Consumer driven health plans (CDHPs) are a growing phenomenon, and ... strategic role to the company, and another to answer customers’ questions directly. , John ...
(Date:8/31/2015)... ... 31, 2015 , ... The Brooks Group, a global sales ... department devoted to helping organizations identify and keep the best talent both inside ... Brooks Group believes in offering a solution that goes beyond simply providing assessments ...
(Date:8/31/2015)... ... August 31, 2015 , ... Now here’s some good health news: Nearly two-thirds ... half your grains whole,” with the majority of Americans eating more whole grains than ... (WGC) released these findings and others from the 2015 Whole Grains Consumer Insights ...
(Date:8/31/2015)... ... August 31, 2015 , ... ... ACTION. NOT CHANCES. (SM) will be featured on a digital screen projected above ... is designed to inspire and promote earlier awareness of the symptoms of ovarian ...
Breaking Medicine News(10 mins):Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 2Health News:ZendyHealth Adds Two Prestigious Consumer Driven Health Plan (CDHP) Experts 3Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:Most Americans Now Make Half Their Grains Whole 2Health News:Most Americans Now Make Half Their Grains Whole 3Health News:Most Americans Now Make Half Their Grains Whole 4Health News:Most Americans Now Make Half Their Grains Whole 5Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 2Health News:National Ovarian Cancer Coalition Rolls Out "TAKE ACTION. NOT CHANCES. (SM)" Campaign for September, National Ovarian Cancer Awareness Month 3
... impact of a job burn out. Apart from it affecting ... host of ailments, say Scientists. //This study supports the various ... contribute to high blood pressure, metabolic syndrome, flu, and heart ... revealed that risk of Type 2 Diabetes was almost 1.8 ...
... Polio Eradication Initiatives and now in an effort to ... planned to immunize 22 million children in Bangladesh under ... Bangladesh will carry out the initiatives along with the ... and the U.S. Centers for Disease Control and Prevention ...
... Health of the Kingdom of Saudi Arabia have taken a ... regardless //of age and vaccination status should receive at least ... Saudi Arabia. This decision was conveyed to the Ministry of ... November 21, 2006. ,The Ministry of Health & ...
... last winter and the number is expected to be greater this ... due to an acute shortage in the availability of the vaccine ... jab. The Department of Health had ordered for 15.2 million doses ... far. Researchers warn that those who do not get vaccinated by ...
... Institute of Vaccines and Biological Products, has announced that ... H5N1 vaccine for// humans from chick embryos. ... and cockerels and similar reactions were observed.The observations have ... Vaccines and Biological Products. Its reported that the quality ...
... increasing use of contaminated drug syringes are the main reasons for ... major cities like// Delhi, Mumbai and Chennai, states a new study. ... of men who have sex with men. In Bangalore, for example, ... know how the virus is transmitted, and a large proportion of ...
Cached Medicine News:Health News:Flu Vaccine Shortage In Britain Causes Anxiety 2Health News:Homosexuality, drug abuse increasing HIV in India: study 2
... Tri-Active is the result of ... the combination of three different methods ... to your skin. This treatment is ... of cellulite through the combined action ...
... is a CO2 laser system with ... Its functions in continuous and super-pulsed ... extreme laser intervention delicacy. Excellent as ... it comes with a large LCD ...
... Kowa VK-2 is a professional digital imaging ... the features you need to acquire, analyze, ... because the tools you use the most ... superior results quickly and easily. This high-resolution ...
Pain management can be complicated. But that doesn't mean your PCA infusion system should be. The new SYNDEO PCA Syringe Pump streamlines pain therapy with a powerful combination of intelligent desig...
Medicine Products: